{"id":"W3198671937","doi":"10.1161/circulationaha.121.057063","title":"Amplatzer Amulet Left Atrial Appendage Occluder Versus Watchman Device for Stroke Prophylaxis (Amulet IDE): A Randomized, Controlled Trial","year":2021,"lang":"en","type":"article","venue":"Circulation","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":389,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Biosense Webster; National Institutes of Health; Daiichi-Sankyo; Amgen; Edwards Lifesciences; Cardinal Health; InfraRedx; Regeneron Pharmaceuticals; Medicure; Boston Scientific Corporation; Daiichi Sankyo Europe; Sanofi; European Commission; Pfizer; CSL Behring","keywords":"Atrial fibrillation; Left atrial appendage occlusion; Stroke (engine); Appendage; Randomized controlled trial; Atrial Appendage","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06118803575898777,"score_gpt":0.3467271195957758,"score_spread":0.285539083836788,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}